Building Interdisciplinary Research Careers in Women's Health (BIRCWH) K12 Program
Funding from the NIH-sponsored (National Institutes of Health) BIRCWH program (Building Interdisciplinary Research Careers in Women’s Health) supports career development of junior Ph.D. and M.D. faculty researchers interested in women’s health research. The program provides multidisciplinary training and mentoring to help such faculty establish independent biomedical research careers in areas relevant to women’s health and creates an environment that nurtures interdisciplinary collaborations in focused and interactive research areas that are essential to improving the health of women. UC Davis BIRCWH scholars will address the NIH/ORWH (Office of Research on Women's Health) crosscutting BIRCWH themes of lifespan, sex/gender determinants, health disparities/differences and diversity, and interdisciplinary research and employ one or more of the special emphasis areas of prevention, treatment, and biological and/or behavioral basis of sex and gender determinants.
The goal of the BIRCWH program is to create an academic environment for women’s health researchers at UC Davis that facilitates their career development and encourages paradigm-shifting, interdisciplinary collaboration and team-based research approaches across our campus and beyond to advance research on women’s health and sex differences. Scholars in the BIRCWH program must devote a minimum of 75% of their professional time to their BIRCWH research project with the hope that scholars will develop independent, federally-funded or externally funded research programs. The program will provide select scholars with a salary of up to $100,000 plus benefits at the UC Davis composite rate, as well as up to $25,000 for travel and research expenses each year.
Call for Applications
August 3, 2021
BIRCWH Scholar, Alicia Agnoli's Study on Opioid Dose Tapering Published in August Issue of JAMA
Alicia Agnoli is an assistant professor of Family and Community Medicine at UC Davis School of Medicine. She is first author of a study published Aug. 3 in JAMA, in which a team of UC Davis Health researchers examined the potential risks of opioid dose tapering. Their study found that patients on stable opioid therapy who had their doses tapered had significantly higher rates of overdose and mental health crisis, compared to patients without dose reductions.